<DOC>
	<DOCNO>NCT01341600</DOCNO>
	<brief_summary>Clopidogrel ( also know Plavix ) use commonly patient prevent heart attack condition cause blood clot . Although clopidogrel work many individual , people respond well drug . The variation treatment response may link genetics . This study examine effect clopidogrel population whose gene well know order determine role gene play response various clopidogrel maintenance dos .</brief_summary>
	<brief_title>Clopidogrel PGX Bench Bedside</brief_title>
	<detailed_description>Clopidogrel prodrug high inter-individual response variability . Clopidogrel convert active drug enzyme encode gene name CYP2C19 . Individuals genetically-impaired CYP2C19 metabolism low capacity convert prodrug active form . Consequently , individual low blood level activate form clopidogrel , diminish antiplatelet response , high rate cardiovascular event stent thrombosis . Increasing dos clopidogrel patient represent possible approach manage gene-drug interaction . The purpose study evaluate whether increase dose clopidogrel increase antiplatelet response active metabolite exposure individual genetically reduce CYP2C19 metabolism relative normal CYP2C19 metabolism . The primary objective ass change clopidogrel response exposure three clopidogrel dose level coadministration omeprazole .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Amish men woman 20 70 year age participate PAPI Severe hypertension ( bp &gt; 160/95 mm Hg ) Coexisting malignancy AST ALT &gt; 2 time normal Creatinine &gt; 2.0 Hct &lt; 32 Hct &gt; 50 TSH &lt; 0.40 &gt; 5.50 History bleed disorder gastrointestinal bleeding History unstable angina , MI , angioplasty , coronary artery bypass surgery History atrial fibrillation , stroke transient ischemic attack deep vein thrombosis Type 2 diabetes Thrombocytosis ( platelet count &gt; 500,000 ) thrombocytopenia ( platelet count &lt; 150,000 ) Surgery within six month Clopidogrel allergy Pregnant woman Currently breast feed Omeprazole allergy Prospective participant take medication would affect outcome ( ) measure willingly safely , opinion treat physician study physician , discontinue medication 1 week prior protocol initiation , take vitamin and/or supplement unwilling discontinue use least 1 week prior study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Clopidogrel</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Platelets</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>